| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |